Month: October 2018
-
Ways to Boost Staff Happiness Levels
Employees who are not happy at work tend to be less productive, less loyal and take more sick days than those who are happy.
-
Start-Up Developing Immunometabolism Therapies, Gains $30M Funding
A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells.
-
Infographic — International Space Station Crew Members
Our friends at Statista published a chart showing the nations represented among ISS crew members since it become operational, our infographic for this weekend.
-
Would You Sue For Compensation If This Happened To You?
Read on to delve into some of the most unusual and famous personal injury claims today.
-
Trials to Test Stem Cell Treatments for Eye Injuries
A series of clinical trials are planned to test the use of adult stem cells to treat injuries to the eyes that lead to vision loss.
-
Biotech in $3.7B Licensing Deal for Hepatitis-B
A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals.
-
DNA Home Testing — Is It Worth It?
While so many of us are able to send away for one of those home testing kits to find out our ancestry, not to mention if we have a predilection towards certain diseases, are these kits valid at all?
-
Artificial Pancreas Controls Type 1 Diabetes Better Than Insulin Pump Alone
A clinical trial shows a closed-loop algorithm-controlled artificial pancreas system helps people with type 1 diabetes better control their blood sugar levels than a glucose sensor and insulin pump system alone.
-
Jet Fuel from Carbon Waste Powers Virgin Atlantic Flight
A Virgin Atlantic flight arriving earlier today from Orlando, Florida to London’s Gatwick airport is the first to use a biofuel made from fermented carbon-rich industrial waste gases.
-
Make Fewer Mistakes In Your Lab
To avoid making mistakes, you should adhere to the following.